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Damage to cellular DNA can result in
the loss of genetic information, in cell-
cycle arrest or even in cell death. So
DNA is constantly surveyed for the
presence of lesions and appropriate
responses are mounted: failure can
lead to genomic instability, mutations
and ultimately cancer. In the last few
years, rapid progress has been made in
understanding many aspects of DNA
repair. For example, it has been found
that tumours from patients with a
hereditary form of colon cancer are
defective in the repair of base
mismatches in DNA. In addition, the
genes involved in a number of
chromosome-instability syndromes
have been cloned. This primer will
look at the repair of eukaryotic DNA
by excision and what the recent
findings tell us about DNA damage
and repair in relation to disease.
What causes DNA damage?
DNA damaging agents can be
divided into two main types,
endogenous and exogenous, each of
which can either lead to cell death or
introduce mutations that will affect
later generations. Water, oxygen and
errors in base-pairing introduced
during replication are the major
endogenous sources of damage.
Thus, hydrolysis is responsible for
the deamination of DNA bases (for
example of cytosine to uracil), and
spontaneous hydrolysis of the
glycosyl bond between purines and
deoxyribose sugars is thought to
remove the base from around 5000
sites in DNA each day in human
cells. Active oxygen species, such as
hydroxyl and superoxide radicals,
arise during normal aerobic
metabolism; guanine and thymine are
their most significant targets in DNA.
DNA is also subject to non-enzymatic
methylation by endogenous
chemicals, producing several adducts,
including O6-methylguanine and
3-methyladenine.
Exogenous DNA-damaging
agents include ultraviolet (UV) light
and ionizing irradiation. Dipyrimidine
photoproducts, formed from two
adjacent pyrimidine residues, are the
major lesions produced by UV
irradiation, but UV can also damage
individual bases. In contrast, ionizing
radiation (such as g rays and X rays)
can produce potentially lethal double-
and single-strand breaks in DNA (the
repair of which will not be considered
further here); ionizing radiation can
also lead to the production of active
oxygen species.
Responses to DNA damage
Many types of DNA damage provoke
stabilization of the p53 tumour
suppressor protein; this stabilization
has been linked to ‘checkpoint’
arrest of the cell cycle at the G1–S
and G2–M phases, before DNA
replication and mitosis, respectively;
arrest is thought to allow time for
cells to effect DNA repair.
The three main mechanisms by
which DNA damage is repaired —
direct reversal, recombination and
excision — are best understood in the
bacterium Escherichia coli but are
generally conserved (although often
more complex) in eukaryotes. The
first two of these mechanisms are
relatively rare. Direct reversal of
damage occurs, for example, in the
removal of the methyl group from the
6 position of guanine by the O6-
methylguanine DNA methyl-
transferase. The effects of damage
can sometimes be circumvented by
tolerating the presence of a lesion in
the genome; frequently this tolerance
is mediated by recombination before
replication. The predominant form of
repair is by excision. 
Excision repair
Repair by excision can be divided
into three types: repair involving base
excision, repair involving nucleotide
excision, and DNA-mismatch repair.
The same essential principles apply
to all three: the damaged region is
recognized, it is removed, and a DNA
polymerase and ligase replace the lost
information and restore the DNA to
its original state. However, the three
pathways operate in different ways
and on distinct types and sizes of
lesion, with little or no overlap
between the enzymes involved. 
Base excision–repair
Base excision–repair is essential in
repairing endogenous DNA damage;
generally, it removes relatively small
lesions that do not substantially
distort the DNA helix. Base
excision–repair is usually initiated by
DNA glycosylases. Recent structural
studies have shown that the
uracil–DNA glycosylase enzyme, for
example, flips its target uracil out of
the DNA into the enzyme’s active
site, whilst minimizing distortion of
the DNA double helix. The ensuing
reaction leads to the formation of a
single-nucleotide gap which is filled
by repair-linked DNA replication. 
The complete pathway of repair
of uracil-containing DNA has been
fully reconstituted using purified E.
coli proteins; base excision–repair in
mammalian cells is very similar but
less well characterized (Fig. 1). The
enzymes act sequentially and, in
some cases, base removal seems to
be the rate-limiting step. Some DNA
glycosylases are highly specific
whereas others have rather broad
substrate specificity. Notably, the
specificities of the enzymes involved
in the early stages of base
excision–repair frequently overlap,
providing back-up for each other. 
In general, DNA glycosylases
recognize and remove damaged DNA
bases. In mammalian cells, however,
a particular DNA glycosylase
removes thymine from G·T mispairs
formed when 5-methylcytosine is
deaminated. Unlike uracil-DNA
glycosylase, which acts rapidly, this
activity is sluggish, perhaps
accounting for the high proportion of
GC to AT mutations at CpG sites in
human tumours. The study of
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mammalian base excision–repair lags
behind studies of the other
excision–repair pathways because no
naturally occurring mutants have
been found — perhaps as a result of
the back-up provided by overlapping
enzyme specificities. Mouse genes
are now being targeted and
‘knockouts’ generated, which should
redress the balance.
Nucleotide excision–repair
Nucleotide excision–repair acts on
bulky, helix-distorting lesions, such as
the dipyrimidine photoproducts
generated by UV light. The lesion is
recognized, incisions are made some
distance away along the DNA strand
and a stretch of around 30 nucleotides
is excised. In contrast to the proteins
involved in base excision–repair,
nucleotide excision–repair factors are
present in a multiprotein complex
and act in a highly concerted manner,
protecting the large DNA gap from
digestion by non-specific nucleases.
The entire process requires 25–30
gene products.
Many of the proteins involved
have recently been identified.
Several are encoded by the genes
responsible for the different
complementation groups of the
related human diseases xeroderma
pigmentosum (XP) and Cockayne’s
syndrome (CS). People with XP are
hypersensitive to sunlight, are
predisposed to skin cancers and may
also have severe neurological
abnormalities. The symptoms of
people with CS include severe
growth retardation, sensitivity to
sunlight, and an average life-span of
only 12 years; CS patients are not
unusually prone to cancer, however. 
Several additional gene products
involved in nucleotide excision–
repair, known as ERCC proteins,
have been isolated as a result of their
ability to complement UV-sensitive
rodent cells. The nucleotide
excision–repair pathway (Fig. 2a) has
recently been reconstituted in vitro
using highly purified proteins. One
significant recent finding is that
some proteins involved in nucleotide
excision–repair also function in basal
transcription. For example, the
products of the XPB and XPD genes
are components of the transcription
factor TFIIH, part of the RNA
polymerase II transcription-initiation
complex. 
It has been known for some time
that mammalian cells assign
nucleotide excision–repair activity to
areas where it is most needed,
removing some types of damage
more rapidly from transcribed than
non-transcribed DNA. In addition,
the DNA strand used as the template
for transcription is repaired
preferentially. Such transcription-
coupled repair also occurs in E. coli,
where RNA polymerase stalled at a
lesion is released from DNA by the
Mfd (for ‘mutation frequency
decline’) helicase, which then recruits
an E. coli damage-recognition protein
to the site. Patients with CS have a
defect in transcription-coupled repair,
and the product of the CSB gene
seems to act in the same way as Mfd.
DNA-mismatch repair
The normal role of DNA-mismatch
repair is to reverse errors that result
from misincorporation by DNA
polymerases and are missed by the
polymerases’ proofreading function.
Mismatch repair also operates during
recombination and removes
inappropriate bases from ‘resting’
DNA. The two types of error
introduced by DNA polymerases
during replication are single-base
mismatches and unpaired bases
resulting from transient misalignment
of template and daughter DNA; the
formation of these looped-out bases is
thought to be enhanced in simple
repetitive (microsatellite) genomic
sequences. In E. coli, the MutS
protein recognizes both single-base
mismatches and loops up to four
bases in size. MutL interacts with
MutS to activate a sequence-specific
endonuclease that cleaves the newly
replicated strand some distance away
from the mismatch. A helicase aids
entry of exonucleases, which degrade
DNA in either a 3′ to 5′ or 5′ to 3′
direction from the incision, up to and
past the site of the mispair. The gap,
which can be thousands of nucleo-
tides long, is filled in by repair–
replication. The process is similar in
eukaryotes (see Fig. 2b and below).
DNA repair and cancer
Recently, a direct involvement of
DNA mismatch repair in cancer has
been uncovered. Individuals
suffering from hereditary non-
polyposis colon cancer (HNPCC) are
predisposed to colon, endometrial
and ovarian tumours. During the
course of mapping a susceptibility
gene, it was found that DNA from
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Figure 1
The main pathway of base excision–repair. A
DNA glycosylase removes the aberrant base
(in this case, uracil). An endonuclease then
cleaves DNA 5′ to the abasic site. The
resulting 5′ deoxyribose moiety is removed by
a deoxyribose phosphodiesterase, and repair
synthesis fills the single-base gap (DNA
polymerase b can fulfil both functions in
mammals). The free ends are then ligated. 
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the patients’ tumours exhibited an
instability in microsatellite repeat
sequences found throughout the
genome. This similarity between
mismatch repair-defective E. coli or
yeast and HNPCC tumours
suggested that these patients might
be defective in mismatch correction.
A human homologue of the yeast and
E. coli mutS genes, hMSH2, was
mapped to the HNPCC
susceptibility region on chromosome
2, and mutations in hMSH2 were
found to segregate with the disease
in several HNPCC families. A
second HNPCC gene, the mutL
homologue hMLH1, was mapped to
chromosome 3. Between them, these
two genes account for around 90 % of
HNPCC cases; the remainder are
probably due to mutations in one of
two other mutL homologues, hPMS1
and hPMS2. Mutations in hMSH2 and
hMLH1 are also found in some of the
sporadic colon tumours that exhibit
microsatellite instability. 
In addition to the HNPCC genes,
at least two other mismatch repair
proteins have been identified by
biochemical criteria. GTBP (hMSH6)
and hMSH3 (DUG1/hMRP-1) are also
mutS homologues. The products of
both probably form heterodimers
with the hMSH2 protein to
participate in mismatch recognition.
Mice lacking MSH2 are viable but
prone to cancer and their cells are
resistant to the cytotoxic effects of
chemicals that produce O6-
methylguanine; this result is
consistent with the isolation of cell
lines resistant to methylating agents
that proved to be defective in
mismatch correction. Male mice
lacking the PMS2 gene are sterile
and have a defect in meiosis,
confirming the role of this mismatch
repair protein in recombination.
Interestingly, recent studies suggest
that some mismatch repair proteins
are also involved in transcription-
coupled nucleotide excision–repair.
Chromosome-instability syndromes
As well as HNPCC and XP, Bloom’s
syndrome (BS) and ataxia–
telangiectasia (AT) are genetic
disorders characterized by
chromosome instability and cancer
predisposition. Cells from patients
with AT are extremely sensitive to
ionizing radiation and have abnormal
radiation-induced cell-cycle
checkpoint controls. It was therefore
very satisfying to learn recently that
the gene defective in AT patients
encodes a protein homologous to
phosphatidylinositol-3 kinases and
other enzymes known to be involved
in checkpoint controls and signal
transduction pathways. BS patients
have stunted growth and are
sensitive to some DNA-damaging
agents; unfortunately, the recent
cloning of the BS gene (although an
elegant technical feat), and the
finding that its product has homology
to a DNA helicase, does little to
explain the problems of BS patients.
It is probably because DNA repair
impinges on so many fundamental
processes and so many diseases that its
study has recently become rather
fashionable. As discussed here, defects
in DNA repair may lead to defects in
transcription and cell-cycle control,
developmental and neurological
abnormalities, and to cancer.
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Figure 2
(a) Nucleotide excision–repair in mammalian
cells. The initial step involves damage
recognition by XPA, which is aided by
replication protein A (RPA). The XPB and
XPD helicases (part of the TFIIH complex)
unwind the DNA to facilitate incision on
either side of the lesion. The 3′ incision is
catalyzed by XPG, and the 5′ incision is
brought about by a complex containing XPF
and ERCC1. Repair-replication is carried out
by DNA polymerase e and accessory factors,
and the DNA is ligated. (b) Model for the
repair of single-base mispairs in human cells.
The hMSH2–hMSH6 heterodimer recognizes
the mispair and interacts with a heterodimer of
MutL homologues. The signal directing repair
to the newly replicated strand is not known for
eukaryotes, but a single-strand break suffices
in vitro. An a-type DNA polymerase performs
repair replication and a DNA ligase seals the
DNA backbone; hMSH2 is thought to interact
with hMSH3 to repair loops.
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